PatternsRadar
Sign in

BPLPHARMABPLPHARMA

NSE
Full chart
1,836.40INR+109.50 (+6.34%)Close · 6 Oct 2026
—Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,266 CrMarket cap
—P/E (TTM)
33.8%Delivery

Filings & corporate actions

CSV
Dividend
₹1.00 per share · last 11 Sept 2026
2026
  • 11 SeptdividendDividend · ₹1.00 per share-3.4%

Growth

CSV
Revenue YoY—
Profit YoY—
Interest cost YoY—
Revenue QoQ—
Profit QoQ—
CAGR2Y3Y4Y5Y6Y7Y
Revenue——————
Profit——————

Key data

CSV
Open1,758.20
Day range1,741.30 – 1,899.00
52-week range—
From 52w high—
RSI (14)61.0
ATR (14)145.54
Volume11.3K
Avg volume (20D)16.5K
Rel volume0.69×
Volatility (1Y)81.2%
Turnover₹2.1Cr
SMA 50 / 200— / —

Delivery percentage

Latest · 6 Oct 202633.8%
20-day avg64.2%
1-year avg65.8%
Percentile (own history)3rd
Range33.8–97.3%
Sessions35

Over the last 20 sessions BPLPHARMA settled 64.2% of its traded quantity, which is unusually high for an NSE equity.

What delivery percentage measuresScan the whole market on delivery

Performance returns

CSV
1D1W1M3M6M1Y
Price+6.34%-14.58%+20.75%———

Valuation

CSV
Market cap₹1,266 Cr
P/E (TTM)—
EPS (TTM)—
Shares outstanding—
Listed17 Aug 2026

Ownership

Promoter—
Promoter Δ QoQ—
Public—
FII—
DII—
Pledged—

BPLPHARMA at a glance

  • BPLPHARMA closed at ₹1,836.4 on 6 Oct 2026, +6.34% on the day.
  • Delivery was 33.8% of traded quantity on 6 Oct 2026, the 3rd percentile of its own 35 sessions with a reading (20-session average 64.2%, 1-year average 65.8%).
  • Market capitalisation is ₹1,266 crore, with no positive trailing earnings for a P/E.